Medical Condition News

RSS

Long term exposure to particulate matter in outdoor air linked to heart attacks and angina

Long term exposure to particulate matter in outdoor air is strongly linked to heart attacks and angina, and this association persists at levels of exposure below the current European limits, suggests research conducted at the Department of Epidemiology in Rome, Italy and published on bmj.com today.

21 Jan 2014

Kolltan Pharmaceuticals announces treatment of first cancer patient with KTN3379

Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced treatment of the first cancer patient with Kolltan's lead drug candidate, KTN3379, as part of a Phase 1 clinical study evaluating safety, preliminary evidence of antitumor activity, and pharmacokinetics. KTN3379 is a human monoclonal antibody that blocks the activity of ErbB3, a member of the ErbB family of receptor tyrosine kinases.

21 Jan 2014

Study: Probability of blindness due to glaucoma has decreased by nearly half

The probability of blindness due to the serious eye disease glaucoma has decreased by nearly half since 1980, according to a study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. The researchers speculate that advances in diagnosis and therapy are likely causes for the decrease, but caution that a significant proportion of patients still progress to blindness.

21 Jan 2014

Agenus' Prophage vaccine Phase 2 study hailed in Neuro-Oncology journal

Agenus Inc., a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, announced that Phase 2 results of Prophage G-200 vaccine in recurrent patients with glioblastoma multiforme were hailed as 'exciting' and a 'very promising therapy' in an editorial published in Neuro-Oncology, the leading journal of the Society of Neuro-Oncology.

21 Jan 2014

Dakim introduces new tool to monitor cognitive performance of residents in senior living communities

Dakim, Inc., the leader in cognitive therapy in the senior living market, has introduced BrainTrac, a new tool that monitors the cognitive performance of residents in senior living communities who use the Dakim BrainFitness system.

21 Jan 2014

Novo Nordisk launches insulin delivery device NovoPen Echo in the U.S.

Novo Nordisk, a world leader in diabetes care, today announced the launch of the insulin delivery device NovoPen Echo in the United States. This is the first and only pen device available in the U.S. with half-unit dosing and a memory function that records the dose and time passed since the last injection.

From Novo Nordisk 21 Jan 2014

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Advaxis, Inc., a leader in developing the next generation of cancer immunotherapies, announced that the first patient has been dosed in a Phase 1/2 "window of opportunity" study being conducted by the Icahn School of Medicine at Mount Sinai. Patients diagnosed with HPV-associated head and neck cancer will receive ADXS-HPV immunotherapy during the "window" of time between initial diagnosis and minimally invasive transoral robotic surgery to remove their tumors.

21 Jan 2014

Alexion's Soliris gets FDA orphan drug designation for DGF prevention in renal transplant patients

Alexion Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted an orphan drug designation to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of delayed graft function in renal transplant patients.

21 Jan 2014

BioLineRx gets approval to begin CE Mark registration trial of BL-5010P for skin lesion treatment

BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that it has received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to commence a pivotal, CE Mark registration trial for BL-5010P, for the non-surgical removal of benign skin lesions.

21 Jan 2014

Football Fans in Training programme can help men lose weight, finds new research

An initiative that helps male football fans feel better and live a healthier lifestyle by losing weight, taking more exercise, and improving their diet has been a resounding success, according to new research published in The Lancet and BMC Public Health.

21 Jan 2014

Splicing factor SRSF6 promotes hyperplasia of sensitized skin

Normally, tissue injury triggers a mechanism in cells that tries to repair damaged tissue and restore the skin to a normal, or homeostatic state. Errors in this process can give rise to various problems, such as chronic inflammation, which is a known cause of certain cancers.

21 Jan 2014

Researchers identify molecular mechanism by which cocaine alters brain's reward circuits, causes addiction

Researchers from the Icahn School of Medicine at Mount Sinai have identified a new molecular mechanism by which cocaine alters the brain's reward circuits and causes addiction.

21 Jan 2014

Tips to prevent winter sport injuries

The first snowfall can only mean a few things: skiing, snowboarding and sledding. But some of the best things about the falling temperatures can also be the most dangerous.

21 Jan 2014

Middle-school girls often continue playing soccer with concussion symptoms

Concussions are common among middle-school girls who play soccer, and most continue to play with symptoms, according to a study by John W. O' Kane, M.D., of the University of Washington Sports Medicine Clinic, Seattle, and colleagues.

20 Jan 2014

Patients with MS could stave off disease symptoms by increasing vitamin D intake

For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health (HSPH) investigators in collaboration with Bayer HealthCare.

20 Jan 2014

New technology may provide solution to high risk of repeat heart attacks, say scientists

Up to 30 percent of heart attack patients suffer a new heart attack because cardiologists are unable to control inflammation inside heart arteries — the process that leads to clots rupturing and causing myocardial infarction or stroke.

20 Jan 2014

Norris Cotton Cancer Center research estimates impact of R rating for movie smoking

The connection between smoking in films and its influence on adolescent behavior is well established by research and its impact was listed today in consumer materials accompanying the Surgeon General's Report: The Health Consequences of Smoking: 50 Years of Progress

20 Jan 2014

Novo Nordisk to use Trialbee's services for e-recruitment of patients for clinical studies

Trialbee has developed a web based platform and methodology which enable the Novo Nordisk to perform fast and effective patient recruitment to specific clinical trials. Trialbee helps reduce the time required for recruitment resulting in important efficiency gains for the pharmaceutical company.

20 Jan 2014

EBCC-9: Most exciting breast cancer conference in Europe

The most exciting breast cancer conference in Europe, it is the only one that involves all the major players in breast cancer. The conference encourages interaction and collaboration between clinicians, scientists and patients in a partnership of equals to talk not just about scientific advances, but also the ethical, social, political, and practical issues associated with caring for patients with breast cancer. EBCC-9 is expected to attract around 5000 delegates from around 90 countries worldwide.

20 Jan 2014

Vitamin D deficiency may lead to stiffening of blood vessels

UV-B radiation in sunlight is the most important factor for the production of vitamin D, and that is why many people suffer from low levels of vitamin D during the winter months.

20 Jan 2014

Medical Condition News

Long term exposure to particulate matter in outdoor air linked to heart attacks and angina

Kolltan Pharmaceuticals announces treatment of first cancer patient with KTN3379

Study: Probability of blindness due to glaucoma has decreased by nearly half

Agenus' Prophage vaccine Phase 2 study hailed in Neuro-Oncology journal

Dakim introduces new tool to monitor cognitive performance of residents in senior living communities

Novo Nordisk launches insulin delivery device NovoPen Echo in the U.S.

First patient dosed in ADXS-HPV Phase 1/2 study for HPV-associated head and neck cancer

Alexion's Soliris gets FDA orphan drug designation for DGF prevention in renal transplant patients

BioLineRx gets approval to begin CE Mark registration trial of BL-5010P for skin lesion treatment

Football Fans in Training programme can help men lose weight, finds new research

Splicing factor SRSF6 promotes hyperplasia of sensitized skin

Researchers identify molecular mechanism by which cocaine alters brain's reward circuits, causes addiction

Tips to prevent winter sport injuries

Middle-school girls often continue playing soccer with concussion symptoms

Patients with MS could stave off disease symptoms by increasing vitamin D intake

New technology may provide solution to high risk of repeat heart attacks, say scientists

Norris Cotton Cancer Center research estimates impact of R rating for movie smoking

Novo Nordisk to use Trialbee's services for e-recruitment of patients for clinical studies

EBCC-9: Most exciting breast cancer conference in Europe

Vitamin D deficiency may lead to stiffening of blood vessels

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News